Prognostic Impact of Charlson Comorbidity Index Obtained from Medical Records and Claims Data on 1-year Mortality and Length of Stay in Gastric Cancer Patients
Open Access
- 1 January 2009
- journal article
- abstracts
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 42 (2) , 117-122
Abstract
We tried to evaluate the agreement of the Charlson comorbidity index values (CCI) obtained from different sources (medical records and National Health Insurance claims data) for gastric cancer patients. We also attempted to assess the prognostic value of these data for predicting 1-year mortality and length of the hospital stay (length of stay). Medical records of 284 gastric cancer patients were reviewed, and their National Health Insurance claims data and death certificates were also investigated. To evaluate agreement, the kappa coefficient was tested. Multiple logistic regression analysis and multiple linear regression analysis were performed to evaluate and compare the prognostic power for predicting 1 year mortality and length of stay. The CCI values for each comorbid condition obtained from 2 different data sources appeared to poorly agree (kappa: 0.00-0.59). It was appeared that the CCI values based on both sources were not valid prognostic indicators of 1-year mortality. Only medical record-based CCI was a valid prognostic indicator of length of stay, even after adjustment of covariables (beta=0.112, 95% CI=[0.017-1.267]). There was a discrepancy between the data sources with regard to the value of CCI both for the prognostic power and its direction. Therefore, assuming that medical records are the gold standard for the source for CCI measurement, claims data is not an appropriate source for determining the CCI, at least for gastric cancer.Keywords
This publication has 23 references indexed in Scilit:
- Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2005
- The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancerProstate Cancer and Prostatic Diseases, 2005
- Impact of two different comorbidity measures on the 6-month mortality of critically ill cancer patientsIntensive Care Medicine, 2005
- Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2003
- Measuring Comorbidity in Patients With Head and Neck CancerThe Laryngoscope, 2002
- Cancer and comorbidityCancer, 2000
- The Impact of Comorbidity and Age on Survival with Laryngeal CancerEar, Nose & Throat Journal, 1999
- The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast CancerAnnals of Internal Medicine, 1994
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987